Editas Medicine
EDIT
EDIT
205 hedge funds and large institutions have $127M invested in Editas Medicine in 2026 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 58 increasing their positions, 50 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% more funds holding
Funds holding: 195 → 205 (+10)
1.79% more ownership
Funds ownership: 51.17% → 52.96% (+1.8%)
Holders
205
Holding in Top 10
–
Calls
$1.1M
Puts
$855K
Top Buyers
| 1 | +$4.08M | |
| 2 | +$2.46M | |
| 3 | +$1.97M | |
| 4 |
D.E. Shaw & Co
New York
|
+$1.77M |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$1.54M |
Top Sellers
| 1 | -$2.21M | |
| 2 | -$1.34M | |
| 3 | -$1.3M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$879K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$688K |
